clinical trial · NCT06138613
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Motion SicknessTradipitant
brief summary
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
started
Feb 27, 2023
primary completion
Sep 30, 2027
completion
Dec 30, 2027
last updated
Apr 16, 2026
detailed description
This is an open label study to investigate the efficacy and safety of tradipitant in motion sickness affected male and female participants during events historically known to cause motion sickness.
official title
Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol